Navigation Links
Indevus in Medical News

Endo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009

LEXINGTON, Mass., March 25 /PRNewswire/ -- Endo Pharmaceuticals Solutions Inc. (formerly known as Indevus Pharmaceuticals, Inc.) today commenced an offer to purchase any or all of its outstanding 6.25% Convertible Senior Notes due 2009 in accordance with the indenture governing the Notes, as a res...

Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals

CHADDS FORD, Pa., March 23 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced the successful completion of its acquisition of Indevus Pharmaceuticals, Inc. Endo acquired Indevus through a tender offer and subsequent merger upon which Indevus became a wholly owned sub...

Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals

CHADDS FORD, Pa., March 19 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced the successful completion of the tender offer by its wholly owned subsidiary, BTB Purchaser Inc., for all of the outstanding shares of common stock of Indevus Pharmaceuticals, Inc. (Nasdaq: ...

Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals

CHADDS FORD, Pa., March 2 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it has extended the subsequent offering period of the tender offer by its wholly owned subsidiary, BTB Purchaser Inc., for all of the outstanding shares of common stock of Indevus Pharma...

Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals

Acquisition Adds Marketed Products and Specialty Sales Force in Urology and Endocrinology, Novel Drug-Delivery Technology Combined Pipeline to Include Nine FDA-Approved Therapeutics Conference Call Scheduled for Today at 5:30 pm EST CHADDS FORD, Pa. and LEXINGTON, Mass., Jan. 5 /PR...

FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus

LEXINGTON, Mass., Nov. 1 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's New Drug Application (NDA) for NEBIDO(R), its long-acting injectable testosterone preparation...

Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options

... the possibility that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of indevus is not complementary to Endo; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory ap...

Endo to Present at Bank of America and Merrill Lynch 2009 Health Care Conference

... the possibility that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of indevus is not complementary to Endo; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory ap...

Endo Pharmaceuticals Reports First Quarter 2009 Financial Results

...cluding results beginning on February 23, 2009 for indevus Pharmaceuticals, which Endo acquired during the qu...ucts recently obtained through our acquisition of indevus Pharmaceuticals, Inc. for the period February 23, ...r certain generic products. Acquisition of indevus Pharmaceuticals, Inc. During the first quart...

Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show

... the possibility that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of indevus is not complementary to Endo; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory ap...
Indevus in Medical Technology

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

...Nasdaq: ENDP ) and its majority-owned subsidiary indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced ... NEBIDO was licensed by BayerSchering Pharma AG to indevus Pharmaceuticals, a majority interest in which Endo...icals, is available at www.endo.com . About indevus ...

Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments

... the possibility that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of indevus is not complementary to Endo; the potential that market segment growth will not follow historical patterns; general industry conditions and competitio...

Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study

...LEXINGTON, Mass., Feb. 9 /PRNewswire-FirstCall/ -- indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced ...00 be shown conclusively to be safe and effective, indevus intends to seek worldwide marketing approvals, and... used in 73 low-income countries. About indevus ...

Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration

... the possibility that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of indevus is not complementary to Endo; the potential that market segment growth will not follow historical patterns; general industry conditions and competitio...

Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering

... LEXINGTON, Mass., Sept. 26 /PRNewswire/ -- indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today annou... for the exclusive, worldwide rights to pagoclone. indevus previously announced promising data from its 8-wee...le regulatory clearances and customary conditions, indevus will conduct and Teva will reimburse...

Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000

...ended in July 2007. Completion of the HPTN 035 trial is expected later this year. Results from the trial are expected by early 2009. About Indevus indevus Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditi...

Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association

... in the growing market for testosterone therapies. indevus acquired U.S. rights to NEBIDO from Bayer Schering...tment with testosterone therapy. About Indevus indevus Pharmaceuticals, Inc. is a specialty pharmaceutica...itions and related uncertainties; and other risks. indevus undertakes no obligation to publicly update any fo...

Indevus Pharmaceuticals Provides Update on PRO 2000 Program

...5 trial is expected this summer. About Indevus indevus Pharmaceuticals, Inc. is a specialty pharmaceutica...itions and related uncertainties; and other risks. indevus undertakes no obligation to publicly update any fo...on, future events or otherwise. Contact: For indevus Michael W. Rogers Executive Vice President and C...

Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)

...ing market for testosterone replacement therapies. indevus acquired U.S. rights to NEBIDO from Bayer Schering...estosterone replacement therapy. About Indevus indevus Pharmaceuticals, Inc. is a specialty pharmaceutica...itions and related uncertainties; and other risks. indevus undertakes no obligation to publicly update any fo...

Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial

...he United States. About Octreotide Implant The indevus octreotide implant is a proprietary formulation of...e (GH), over a six month period. About Indevus indevus Pharmaceuticals, Inc. is a specialty pharmaceutica...elated litigation; the risk that the businesses of indevus and Valera Pharmaceuticals, Inc. will not be integ...
Indevus in Biological News

MetaChip provides quick, efficient toxicity screening of potential drugs

...ting two topical microbicides with differing mechanisms of action," she adds. The microbicides to be tested are PRO 2000 and BufferGel. Produced by indevus Pharmaceuticals, Lexington, MA, PRO 2000 has shown activity against HIV and other STIs in both laboratory and animal testing. It is believed to act by...

International trial of two microbicides begins

...ting two topical microbicides with differing mechanisms of action," she adds. The microbicides to be tested are PRO 2000 and BufferGel. Produced by indevus Pharmaceuticals, Lexington, MA, PRO 2000 has shown activity against HIV and other STIs in both laboratory and animal testing. It is believed to act by...

Topical treatment shown to inhibit HIV and herpes simplex virus infection

...e study, which was funded by the National Institutes of Health (NIH) investigated the efficacy of PRO 2000, a topical microbicide under development by indevus Pharmaceuticals, Inc. "There is an urgent need for the development of safe and effective vaginal microbicides," Marla Keller, M.D., Assistant Profes...
Indevus in Biological Technology

Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009

Announces that Approximately 89.3 Percent of Outstanding Indevus Shares Have Been Accepted for Purchase CHADDS FORD, Pa., March 16 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that, as of 5:00 p.m., New York City time, on March 13, 2009, approximately 71,00...

Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period

CHADDS FORD, Pa., Feb. 23 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced the successful completion of the tender offer by its wholly owned subsidiary, BTB Purchaser Inc., for all of the outstanding shares of common stock of Indevus Pharmaceuticals, Inc. (Nasdaq: ...

125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative

Indevus encouraging other companies across the country to hold their events in New Orleans and to bring their helping hearts and hands LEXINGTON, Mass., March 20 /PRNewswire-FirstCall/ -- As part of its annual sales meeting being held in New Orleans for the first time, Indevus Pharmaceutic...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...er of 2009, including a full quarter of results of indevus Pharmaceuticals, Inc., which Endo acquired during ... areas that we've entered, with our acquisition of indevus Pharmaceuticals, Inc. earlier this year. Our new ...ue of contingent consideration associated with the indevus transaction and the addition of milestone payments...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...ch Inc., GlaxoSmithKline Plc., Immunomedics, Inc., indevus Pharmaceuticals Inc., Novartis AG, OSI Pharmaceuti...xpands into France with Sonablate(R) 500 II-81 indevus Enters into Agreement to Takeover Valera II-82 ... (UK) II-95 Immunomedics, Inc. (USA) II-95 indevus Pharmaceuticals Inc. (USA) II-95 Novartis AG (...

Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors

... the possibility that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of indevus is not complimentary to Endo; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory ap...

Indevus Pharmaceuticals Announces Release of 2008 Annual Report

...EXINGTON, Mass., Jan. 27 /PRNewswire-FirstCall/ -- indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today anno...t (781) 861-8444 or by mailing written requests to indevus Pharmaceuticals, Inc., Attention Investor Relation...Global Market under the symbol "IDEV." About indevus Pharmaceuticals ...

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

...reement with Teva, this trial will be conducted by indevus and funded by Teva. The results of this trial pro...for 30 days following the live call. About indevus indevus Pharmaceuticals, Inc. is a specialty pharmaceutica...

Indevus Pharmaceuticals to Present at Upcoming Investor Conferences

... web cast live and may be accessed by visiting the Investors section of the indevus website at http://www.indevus.com . About Indevus indevus Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the ...

Indevus and FDA Agree on Path Forward for NEBIDO(R)

... of serious post-injection, oil-based reactions. indevus and FDA also agreed on an education plan to minimi...rity of the serious oil- based reactions. Further, indevus and FDA agreed to obtain skin-testing data to char...drug or any of its excipients in certain patients. indevus has also agreed to conduct a large, simple post- m...
Other Tags
(Date:4/24/2014)... State University researcher has found a relationship between motor ... autism spectrum disorder in very young children. , ... show a direct relationship between motor skills and autism ... skills should be included in treatment plans for young ... in OSU,s College of Public Health and Human Sciences. ...
(Date:4/24/2014)... scientist at the University of York reveals that a ... of the nervous system may also play a pivotal ... research team, led by Dr Will Brackenbury, a Medical ... York, has studied how voltage-gated sodium channels assist in ... in the membranes of excitable cells, such as neurons, ...
(Date:4/23/2014)... Pregnant immigrants from Sub-Saharan Africa, Latin America ... pregnancy, according to new research from St. Michael,s ... British Journal of Obstetrics and Gynaecology , ... among immigrants and native-born women in six high-immigration ... Spain (Catalonia and Valencia) and the United States ...
(Date:4/23/2014)... John J. O,Shea, M.D., scientific director at the National ... has been named the 2014 recipient of the Ross ... peer-reviewed, open-access journal Molecular Medicine . The award ... York Academy of Sciences in Manhattan, followed by scientific ... is part of the National Institutes of Health. , ...
(Date:4/23/2014)... report that rats exposed to high-energy particles, simulating conditions ... show lapses in attention and slower reaction times, even ... ranges. , The cognitive impairments which affected a ... appear to be linked to protein changes in ... to hold true in humans, suggest it may be ...
Breaking Medicine News(10 mins):Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Breast cancer replicates brain development process 2Health News:Pregnancy complications may be more common in immigrants from certain regions 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3
(Date:4/24/2014)... generation of military veterans returning home from Iraq and ... concern in American medical institutions and the culture at-large. ... personnel deployed to Iraq and Afghanistan suffer from PTSD. ... of Medicine is shedding light on how PTSD is ... , The rise in PTSD has implications beyond the ...
(Date:4/24/2014)... droplet of clear liquid can bend light, acting as ... have developed a new process to create inexpensive high ... apiece. , Because they,re so inexpensive, the lenses ... tools to detect diseases in the field, scientific research ... education in classrooms. , "What I,m really excited ...
(Date:4/23/2014)... Africa,s Congo rainforest, the second-largest tropical rainforest in the ... the past decade. , The study, led by Liming ... York, shows between 2000 and 2012 the decline affected ... research, published Wednesday in Nature , is one ... effects of long-term drought on the Congo rainforest using ...
Breaking Biology News(10 mins):New study links inflammation in those with PTSD to changes in microRNA 2New study links inflammation in those with PTSD to changes in microRNA 3Bake your own droplet lens 2Bake your own droplet lens 3NASA satellites show drought may take toll on Congo rainforest 2NASA satellites show drought may take toll on Congo rainforest 3
Other Contents